OBIO Collar Strategy
OBIO (Orchestra BioMed Holdings, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.
OBIO (Orchestra BioMed Holdings, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $237.6M, a beta of 0.52 versus the broader market, a 52-week range of 2.2-5.424, average daily share volume of 202K, a public-listing history dating back to 2020, approximately 70 full-time employees. These structural characteristics shape how OBIO stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.52 indicates OBIO has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a collar on OBIO?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
Current OBIO snapshot
As of May 15, 2026, spot at $3.78, ATM IV 99.00%, IV rank 21.73%, expected move 28.38%. The collar on OBIO below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this collar structure on OBIO specifically: IV regime affects collar pricing on both sides; compressed OBIO IV at 99.00% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 28.38% (roughly $1.07 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated OBIO expiries trade a higher absolute premium for lower per-day decay. Position sizing on OBIO should anchor to the underlying notional of $3.78 per share and to the trader's directional view on OBIO stock.
OBIO collar setup
The OBIO collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With OBIO near $3.78, the first option leg uses a $3.97 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed OBIO chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 OBIO shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $3.78 | long |
| Sell 1 | Call | $3.97 | N/A |
| Buy 1 | Put | $3.59 | N/A |
OBIO collar risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
OBIO collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on OBIO. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use collar on OBIO
Collars on OBIO hedge an existing long OBIO stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
OBIO thesis for this collar
The market-implied 1-standard-deviation range for OBIO extends from approximately $2.71 on the downside to $4.85 on the upside. A OBIO collar hedges an existing long OBIO position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current OBIO IV rank near 21.73% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on OBIO at 99.00%. As a Healthcare name, OBIO options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to OBIO-specific events.
OBIO collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. OBIO positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move OBIO alongside the broader basket even when OBIO-specific fundamentals are unchanged. Always rebuild the position from current OBIO chain quotes before placing a trade.
Frequently asked questions
- What is a collar on OBIO?
- A collar on OBIO is the collar strategy applied to OBIO (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With OBIO stock trading near $3.78, the strikes shown on this page are snapped to the nearest listed OBIO chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are OBIO collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the OBIO collar priced from the end-of-day chain at a 30-day expiry (ATM IV 99.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a OBIO collar?
- The breakeven for the OBIO collar priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current OBIO market-implied 1-standard-deviation expected move is approximately 28.38%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on OBIO?
- Collars on OBIO hedge an existing long OBIO stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current OBIO implied volatility affect this collar?
- OBIO ATM IV is at 99.00% with IV rank near 21.73%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.